Gregor Diagnostics, Inc. — Form D

Gregor Diagnostics, Inc. of Dallas, TX, a company, filed a Form D exempt-offering notice with the SEC on 2019-10-28. The offering totals $1.1M, of which $916K was reported sold. Industry: Biotechnology.

Offering

Filed: 2019-10-28
Form: D
Accession: 0001746381-19-000002
Industry: Biotechnology
Exemptions: 06b
Total offering: $1.1M
Amount sold: $916K
Remaining: $184K
Investors: 8
Date of first sale: 2019-10-18
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-351966

Issuer

Name: Gregor Diagnostics, Inc.
CIK: 0001746381
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2017
Address: 5910 N. Central Expressway, Dallas, TX, 75206
Phone: 608-340-1896

Officers, directors & promoters (10)

Name	Role	Location
Gilbert G Garcia	Director	Dallas, TX
Mike G Bress	Executive Officer	Dallas, TX
Lauren Tyra	Director	Dallas, TX
Lauren Tyra	Executive Officer	Dallas, TX
Michael Partsch	Director	Madison, WI
Tobias Zutz	Director	Dallas, TX
Tobias Zutz	Executive Officer	Dallas, TX
Sundaresh Brahmasandra	Director	Ann Arbor, MI
Steven Weinstein	Director	Dallas, TX
Steven Weinstein	Executive Officer	Dallas, TX

Other filings by this issuer (5)

Filed	Form	Offering	Sold
2025-11-04	D	$250K	$242K
2024-12-16	D/A	$10.0M	$7.4M
2023-10-31	D	$6.0M	$4.4M
2021-10-29	D	$6.6M	$5.0M
2018-07-12	D	$1.0M	$900K

More